文献速递呼吸衰竭与机械通气

急性低氧性呼吸衰竭中高流量氧疗与标准氧疗的比较

High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure.
PubMed 文献 · N Engl J Med · 2026-03-17
一句话结论在急性低氧性呼吸衰竭患者中,高流量鼻导管氧疗未显著降低28天死亡率,但插管率低于标准氧疗。

这项多中心、开放标签试验将1116例急性低氧性呼吸衰竭患者随机分配至高流量氧疗组或标准氧疗组,所有患者PaO2/FiO2≤200、呼吸频率>25次/分且胸部影像有肺浸润。主要终点28天死亡率在高流量组为14.6%,标准氧疗组为14.6%(差值-0.05个百分点,95%CI -4.21至4.10,P=0.98),无显著差异。28天插管率在高流量组为42.4%,标准氧疗组为48.4%(差值-5.93个百分点,95%CI -11.78至-0.08)。高流量组自主呼吸期间严重不良事件(心脏骤停或气胸)发生13例(2.3%),标准氧疗组6例(1.1%)。

要点

  • 急性低氧性呼吸衰竭患者(PaO2/FiO2≤200、呼吸频率>25次/分、胸部影像有肺浸润)使用高流量鼻导管氧疗,28天死亡率14.6% vs 标准氧疗14.6%,无显著差异(P=0.98)。
  • 高流量氧疗组28天插管率42.4%(236/556)vs 标准氧疗组48.4%(268/554),差值-5.93个百分点(95%CI -11.78至-0.08)。
  • 高流量氧疗组自主呼吸期间严重不良事件(心脏骤停或气胸)13例(2.3%),标准氧疗组6例(1.1%)。
  • 该试验为多中心、开放标签设计,纳入1116例患者,1110例纳入分析(高流量组556例,标准氧疗组554例)。

适用人群与场景

  • 急性低氧性呼吸衰竭患者,PaO2/FiO2≤200、呼吸频率>25次/分、胸部影像有肺浸润。

诊断标准与关键阈值

  • 纳入标准:PaO2/FiO2≤200,呼吸频率>25次/分,胸部影像显示肺浸润。

研究设计与关键结果

  • 多中心、开放标签试验,1116例患者随机分组,1110例纳入分析(高流量氧疗组556例,标准氧疗组554例)。
  • 主要终点28天死亡率:高流量氧疗组14.6%(81/556) vs 标准氧疗组14.6%(81/554),差值-0.05个百分点(95%CI -4.21至4.10,P=0.98)。
  • 28天插管率:高流量氧疗组42.4%(236/556) vs 标准氧疗组48.4%(268/554),差值-5.93个百分点(95%CI -11.78至-0.08)。
  • 自主呼吸期间严重不良事件(心脏骤停或气胸):高流量氧疗组13例(2.3%),标准氧疗组6例(1.1%)。

证据类型、等级与局限

  • 证据类型:多中心、开放标签随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在急性低氧性呼吸衰竭患者中,高流量鼻导管氧疗与标准氧疗相比未显著降低28天死亡率,但插管率较低(42.4% vs 48.4%)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory failure.

METHODS: In this multicenter, open-label trial, we randomly assigned patients who had acute hypoxemic respiratory failure to receive high-flow-oxygen or standard-oxygen therapy. All the patients had a ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen of 200 or less, a respiratory rate of more than 25 breaths per minute, and pulmonary infiltrate on chest imaging. The primary outcome was death by day 28.

RESULTS: A total of 1116 patients underwent randomization. Of these patients, 1110 (556 in the high-flow-oxygen group and 554 in the standard-oxygen group) were included in the analysis. Mortality at day 28 was 14.6% (in 81 of 556 patients) in the high-flow-oxygen group and 14.6% (in 81 of 554 patients) in the standard-oxygen group (difference, -0.05 percentage points; 95% confidence interval [CI], -4.21 to 4.10; P = 0.98). The incidence of intubation by day 28 was 42.4% (in 236 of 556 patients) in the high-flow-oxygen group and 48.4% (in 268 of 554 patients) in the standard-oxygen group (difference, -5.93 percentage points; 95% CI, -11.78 to -0.08). Serious adverse events (cardiac arrest or pneumothorax) occurred during spontaneous breathing in 13 patients (2.3%) in the high-flow-oxygen group and in 6 patients (1.1%) in the standard-oxygen group.

CONCLUSIONS: Among patients with acute hypoxemic respiratory failure, the use of oxygen delivered through a high-flow nasal cannula did not significantly reduce mortality at day 28. (Funded by the French Ministry of Health and Fisher and Paykel Healthcare; SOHO ClinicalTrials.gov number, NCT04468126.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Frat JP, Quenot JP, Guitton C, et al. High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure. N Engl J Med. 2026. PMID: 41841715. doi:10.1056/NEJMoa2516087

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。